STAAR Surgical To Present At Piper Jaffray Healthcare Investor Conference
MONROVIA, Calif., Nov. 21, 2013
MONROVIA, Calif., Nov. 21, 2013 /PRNewswire/ -- STAAR Surgical Company
(NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally
invasive ophthalmic products, today announced that Barry Caldwell, President
and CEO, and Steve Brown, CFO, will participate in a fireside chat at the 25th
Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel on
Tuesday, December 3 at 3:00 p.m. ET.
STAAR will offer a live audio webcast of its presentation on the Company's
website, www.staar.com, under Investor Information. An archived replay of the
presentation will be available for 90 days, also at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25
years, designs, develops, manufactures and markets implantable lenses for the
eye and delivery systems therefor. All of these lenses are foldable, which
permits the surgeon to insert them through a small incision. STAAR's lens used
in refractive surgery as an alternative to LASIK is called an Implantable
Collamer® Lens or "ICL." A lens used to replace the natural lens after
cataract surgery is called an intraocular lens or "IOL." Over 375,000 Visian
ICLs have been implanted to date; to learn more about the ICL go to:
www.visianinfo.com. STAAR has approximately 300 full time employees and
markets lenses in over 60 countries. Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA;
and Monrovia, CA. For more information, please visit the Company's website at
Collamer® is the registered trademark for STAAR's proprietary biocompatible
collagen copolymer lens material.
CONTACT: Investors Media
EVC Group EVC Group
Doug Sherk, 415-652-9100 Janine McCargo
Leigh Salvo, 415-568-9348 646-688-0425
SOURCE STAAR Surgical Company
Press spacebar to pause and continue. Press esc to stop.